A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)
Clinical trial NCT06270836 · COMPLETED
Trial details
- NCT number
- NCT06270836
- Sponsor
- Kodiak Sciences Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-02-13
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.